AMPLIGEN

Swiss trademark · 359922 · Word mark · In force

Register entry

Registration number
359922
Application number
00104/1988
Status
In force
Type
Word mark
Filed
Jan 11, 1988
Registered
Mar 21, 1988
Published
May 10, 1988
Protected until
Jan 11, 2028
Source
Swissreg

Goods and services

Pharmaceuticals

Intravenös verwendbare Lösung zur Behandlung von Virusinfektionen.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Oct 18, 2021

    Agent’s address changed

    Representative
    R.A. Egli & Co., Patentanwälte, Horneggstrasse 4, 8008 Zürich → R.A. Egli & Co, Patentanwälte, Baarerstrasse 14, 6300 Zug

    Published in Swissreg on 18.10.2021

  2. Oct 18, 2021

    Holder’s address changed

    Owner
    HEM Research, Inc., 12280 Wilkins Avenue, Rockville (MD), USA → AIM ImmunoTech Inc., 2117 SW Highway 484, Ocala, FL 34473, USA

    Published in Swissreg on 18.10.2021

  3. Jan 17, 2018

    Renewed

    Published in Swissreg on 17.01.2018

  4. Sep 10, 2008

    Renewed

    Published in Swissreg on 10.09.2008

  5. Aug 26, 2008

    Change

    Published in Swissreg on 26.08.2008

  6. Aug 18, 2008

    Deleted, not renewed

    Published in Swissreg on 18.08.2008

  7. May 10, 1988

    Registered

    Published in the SOGC no. 107 of 10.05.1988

Parties

Holder

AIM ImmunoTech Inc.

2117 SW Highway 484, Ocala, FL 34473, US

Agent

R.A. Egli & Co, Patentanwälte

Baarerstrasse 14, 6300 Zug

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.